Philippe Bisel - Concepedia

Author

Philippe Bisel

University of Freiburg

Also Known As

Bisel, P., Bisel, Philippe, P Bisel, P. BISEL, P. Bisel, Philippe Bisel

Publications

704

Citations

H-Index

Concepts

All Affiliations

University of Freiburg University Medical Center Freiburg Kantonsspital St. Gallen Charité - Universitätsmedizin Berlin

About

Philippe Bisel is an author at University of Freiburg specializing in organic chemistry, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	6	6	215
2	Natural Sciences	5	5	205
3	Medicine	4	4	174
4	Engineering	2	2	112
5	Biology	1	1	19

Philippe Bisel

Publications

626

Citations

H-Index

Page 1

	Year	Citations
The tert-butyl group in chemistry and biology Philippe Bisel, Lo′ay A. Al-Momani, Michael Müller Organic & Biomolecular Chemistry EngineeringChemical TransformationMolecular BiologyOrganic ChemistryTert-butyl Group	2008	88
Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics Bjoern Moosmann, Philippe Bisel, Volker Auwärter Drug Testing and Analysis	2014	85
Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites Laura M. Huppertz, Philippe Bisel, Folker Westphal, Forensic Toxicology Pharmacological StudyDrug DesignMedicineVitro MetabolitesOrganic Chemistry	2015	66
Identification of the cannabimimetic AM-1220 and its azepane isomer (N-methylazepan-3-yl)-3-(1-naphthoyl)indole in a research chemical and several herbal mixtures Stefan Kneisel, Philippe Bisel, Volker Brecht, Forensic Toxicology Cannabimimetic Am-1220Medicinal ChemistryMedicineAzepane IsomerHerbal Medicine	2012	49
Identification and structural characterization of the synthetic cannabinoid 3‐(1‐adamantoyl)‐1‐pentylindole as an additive in ‘herbal incense’ Stefan Kneisel, Folker Westphal, Philippe Bisel, Journal of Mass Spectrometry	2012	46
Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL‐PEGACLONE Verena Angerer, Lukas Mogler, Jan‐Patrick Steitz, Drug Testing and Analysis	2017	45
Characterization and <i>in vitro</i> phase I microsomal metabolism of designer benzodiazepines — an update comprising adinazolam, cloniprazepam, fonazepam, 3‐hydroxyphenazepam, metizolam and nitrazolam Bjoern Moosmann, Philippe Bisel, Florian Franz, Journal of Mass Spectrometry Psychotropic MedicationPsychopharmacologyPharmacotherapyDesigner BenzodiazepinesExperimental Pharmacology	2016	40
5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA Verena Angerer, Florian Franz, Bjoern Moosmann, Forensic Toxicology	2018	39
Diastereo- and Enantioselective Synthesis of (+)- and (−)-cis-2-Aminocyclobutanols Philippe Bisel, Elke Breitling, August Wilhelm Frahm European Journal of Organic Chemistry BiochemistryNatural SciencesDiversity-oriented SynthesisCorresponding Salicylidene DerivativesLike Induction	1998	34
Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative NE-CHMIMO using flash chromatography, GC-MS, IR and NMR spectroscopy Verena Angerer, Philippe Bisel, Bjoern Moosmann, Forensic Science International	2016	25

Page 1